X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (718) 718
Publication (70) 70
Patent (19) 19
Book Chapter (17) 17
Book Review (8) 8
Conference Proceeding (2) 2
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (370) 370
male (264) 264
female (218) 218
umcg approved (218) 218
index medicus (209) 209
urology & nephrology (190) 190
middle aged (188) 188
aged (152) 152
risk factors (132) 132
albuminuria (123) 123
adult (114) 114
nephropathy (105) 105
proteinuria (99) 99
animals (98) 98
hypertension (94) 94
mortality (81) 81
blood pressure (80) 80
nephrology (80) 80
glomerular filtration rate (77) 77
diabetes (76) 76
microalbuminuria (76) 76
chronic kidney-disease (74) 74
type 2 diabetes (69) 69
blood pressure - drug effects (66) 66
angiotensin-converting enzyme inhibitors - therapeutic use (64) 64
blood-pressure (64) 64
diabetes mellitus, type 2 - complications (64) 64
progression (64) 64
rats (64) 64
risk (63) 63
disease (62) 62
peripheral vascular disease (60) 60
glomerular-filtration-rate (58) 58
cardiovascular disease (57) 57
kidney diseases (57) 57
double-blind method (54) 54
antihypertensive agents - therapeutic use (53) 53
diabetic nephropathies - drug therapy (49) 49
disease progression (47) 47
pharmacology & pharmacy (46) 46
treatment outcome (46) 46
cardiac & cardiovascular systems (45) 45
kidney - drug effects (45) 45
cardiovascular diseases (44) 44
diabetes mellitus (44) 44
diabetes mellitus, type 2 - drug therapy (44) 44
chronic kidney disease (43) 43
endocrinology & metabolism (43) 43
hypertension - drug therapy (43) 43
proteinuria - drug therapy (43) 43
losartan (42) 42
rats, wistar (42) 42
medicine, general & internal (41) 41
kidney (38) 38
kidney - physiopathology (38) 38
outcomes (38) 38
urinary albumin excretion (38) 38
albuminuria - drug therapy (36) 36
drug therapy (36) 36
transplantation (36) 36
cohort studies (35) 35
diabetic nephropathy (35) 35
population (35) 35
renin-angiotensin system - drug effects (35) 35
diabetic-nephropathy (34) 34
follow-up studies (34) 34
research (33) 33
predictive value of tests (32) 32
prognosis (32) 32
prospective studies (32) 32
time factors (32) 32
ace-inhibition (31) 31
dose-response relationship, drug (31) 31
cardiovascular diseases - prevention & control (30) 30
clinical trials (30) 30
creatinine - blood (30) 30
mellitus (30) 30
cardiovascular diseases - etiology (29) 29
hypertension - physiopathology (29) 29
albuminuria - epidemiology (28) 28
analysis (28) 28
cardiovascular diseases - mortality (28) 28
health aspects (28) 28
metaanalysis (28) 28
abridged index medicus (27) 27
angiotensin-converting enzyme inhibitors - pharmacology (27) 27
creatinine (27) 27
glomerular filtration rate - drug effects (27) 27
heart failure (27) 27
kidney failure, chronic - prevention & control (27) 27
prevention (27) 27
angiotensin (26) 26
drug therapy, combination (26) 26
medicine (26) 26
renal-disease (26) 26
stage renal-disease (25) 25
albuminuria - diagnosis (24) 24
angiotensin ii type 1 receptor blockers - therapeutic use (24) 24
care and treatment (24) 24
complications and side effects (24) 24
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (757) 757
Dutch (19) 19
French (9) 9
German (5) 5
Chinese (1) 1
Danish (1) 1
Japanese (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 11/2011, Volume 124, Issue 18, pp. F103 - F105
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 7, pp. 644 - 657
In this report of two randomized trials, patients with type 2 diabetes at risk for cardiovascular disease received the sodium–glucose cotransporter 2 inhibitor... 
METAANALYSIS | ATRIAL-NATRIURETIC-PEPTIDE | RATIONALE | INTENSIVE GLUCOSE CONTROL | PLACEBO-CONTROLLED TRIAL | OUTCOMES | INHIBITORS | STAGE KIDNEY-DISEASE | PROGRESSION | BASE-LINE CHARACTERISTICS | MEDICINE, GENERAL & INTERNAL | Hypoglycemic Agents - therapeutic use | Albuminuria - complications | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hospitalization - statistics & numerical data | Kidney Diseases - mortality | Male | Canagliflozin - adverse effects | Disease Progression | Foot - surgery | Glomerular Filtration Rate - drug effects | Diabetes Mellitus, Type 2 - physiopathology | Canagliflozin - therapeutic use | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Aged | Amputation - statistics & numerical data | Kidney Diseases - etiology | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Type 2 diabetes | Heart | Complications and side effects | Care and treatment | Abnormalities | Amputation | Myocardial infarction | Heart attacks | Body weight | Clinical trials | Cardiovascular disease | Blood pressure | Drug dosages | Heart failure | Cerebral infarction | Stroke | Statistical analysis | Kidneys | Metatarsal | Diabetes mellitus | Toe | FDA approval | Glomerular filtration rate | Medicine | Studies | Side effects | Sodium | Diabetes | Kidney diseases | Cardiovascular diseases | Health risk assessment | Kidney transplantation
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9784, pp. 2181 - 2192
Summary Background Lowering LDL cholesterol with statin regimens reduces the risk of myocardial infarction, ischaemic stroke, and the need for coronary... 
Internal Medicine | UNITED-KINGDOM HEART | DESIGN | METAANALYSIS | REQUIRING PROLONGED OBSERVATION | EFFICACY | CARDIOVASCULAR EVENTS | SAFETY | HEMODIALYSIS | OUTCOMES | UMCG Approved | PARTICIPANTS | MEDICINE, GENERAL & INTERNAL | Confidence Intervals | Simvastatin - adverse effects | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Ezetimibe | Renal Dialysis - methods | Male | Reference Values | Cholesterol, LDL - analysis | Kidney Function Tests | Renal Insufficiency, Chronic - drug therapy | Dose-Response Relationship, Drug | Renal Insufficiency, Chronic - therapy | Renal Dialysis - mortality | Time Factors | Renal Insufficiency, Chronic - mortality | Adult | Female | Renal Insufficiency, Chronic - diagnosis | Drug Therapy, Combination | Severity of Illness Index | Hypolipidemic Agents - adverse effects | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Simvastatin - administration & dosage | Cholesterol, LDL - drug effects | Treatment Outcome | Azetidines - administration & dosage | Hypolipidemic Agents - administration & dosage | Survival Analysis | Aged | Simvastatin | Low density lipoproteins | Physiological aspects | Drug therapy, Combination | Research | Kidney diseases | Diagnosis | Drug therapy | Health aspects | Studies | Heart failure | Cardiac arrhythmia | Medical imaging | Hospitals | Compliance | Cardiovascular disease | Blood pressure | Family medical history | Cholesterol | Cancer | Mortality | myocardial infarction | cholesterol | councils | Dialysis | medical research | stroke | Kidney | Fast track | Pharmaceutical Sciences | Basic Medicine | PHARMACY | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | FARMACI | Farmaceutiska vetenskaper
Journal Article